-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
At present, the new crown vaccination campaign has been widely launched in China.
The new crown inactivated vaccine developed by the Wuhan Institute of Biological Products and Beijing Institute of Biological Products under Sinopharm China Biotechnology Co.
Two new inactivated vaccines developed by the Wuhan Institute of Biology and Beijing were approved to be included in the emergency use of China's new crown vaccine in June and July 2020.
The overall adverse reaction rate is low, and no serious adverse reactions have been found
The overall adverse reaction rate is low, and no serious adverse reactions have been foundThe system monitored a total of 519,543 vaccination information and found 5164 pieces of adverse reaction information.
Picture source: reference [1]
Adverse reactions of vaccination are generally relieved within 3-4 days
Adverse reactions of vaccination are generally relieved within 3-4 daysSafety information shows that local reactions after vaccination mainly occur on the day of vaccination and within 24 hours after vaccination.
Reference materials [1]
The lowest adverse reaction rate among the elderly over 60
The lowest adverse reaction rate among the elderly over 60Analyzing the incidence of adverse reactions according to population characteristics, it was found that the incidence of adverse reactions in women was 1.
According to age, the incidence of adverse reactions was the highest among people aged 12-18, reaching 11.
Picture source: reference [1]
Some discussion
Some discussionDuring the discussion of the paper, the researchers pointed out that the safety data obtained during this emergency use process was significantly better than the safety results of the inactivated vaccine in the phase 2 clinical trial.
The types of adverse reactions found in this study are similar to those in clinical trials, and compared with other types of inactivated vaccines, the adverse reaction rate of the new coronavirus inactivated vaccine is also relatively low.
The author pointed out at the end of the paper that increasing the vaccination rate and gradually establishing herd immunity is one of the most effective ways to stop the spread of the new crown epidemic.
Reference materials:
[1] Yang et al.
Note: This article aims to introduce the progress of medical and health research, not to recommend treatment options.